The prevalence of KRAS mutations in pancreatic tumors is striking, with mutations of the KRAS gene being present in 90–95% of pancreatic adenocarcinomas, making it the most frequently mutated gene in this type of cancer [97]. The gene discussed is KRAS; the disease is pancreatic neoplasm.